Reprint
Recent Advances in the Treatment of Hypertension
Edited by
September 2023
168 pages
- ISBN978-3-0365-8793-6 (Hardback)
- ISBN978-3-0365-8792-9 (PDF)
This book is a reprint of the Special Issue Recent Advances in the Treatment of Hypertension that was published in
Biology & Life Sciences
Medicine & Pharmacology
Summary
The reprint collects several articles discussing pathophysiology, risk stratification, control and management of hypertension. Two research articles also evaluated the role of hypertension in the pandemic era of the severe acute respiratory syndrome Coronavirus 2 infection.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
SARS-CoV-2; COVID-19; renin–angiotensin system; ACE2; ACE inhibitors; angiotensin receptor blockers; angiotensin-converting enzyme inhibitors; hypertension; antihypertensive therapy; renal denervation; diabetes; heart failure; chronic disease; hypertension; atrial fibrillation; primary hyperaldosteronism; antihypertensive agents; artificial pacemakers; anticoagulants; arterial hypertension; endothelial dysfunction; occupational medicine; heart failure; chronic disease; arginine; rehabilitation; exercise; outcome; cardiovascular disease; hypertension; chronic kidney disease; blood pressure targets; intensive blood pressure control; renal outcomes; cardiovascular outcomes; COVID-19; vaccine; blood pressure; hypertension; adverse drug reaction; BNT162b2; mRNA-1273; Ad26.COV2.S; CVnCoV; ChAdOx1nCoV-19; NVX-CoV2373; Gam-COVID-Vac; high-intensity interval training; continuous aerobic training; systolic blood pressure; diastolic blood pressure; pre-hypertension; arterial stiffness; cardio-ankle vascular index; cardiovascular events; risk factors; blood pressure management; endothelial function; endothelial structure; H-type hypertension; hyperhomocysteinemia; MTHFR C677T; sub-Saharan Africa; vascular inflammation; hypertension; artificial intelligence; machine learning; blood pressure; deep learning; deep neural networks; big data; wearable technology; digital health; photoplethysmograph; hypertension control; primary care; clinical trial; n/a